Thrombophilia clinical trials
The registry lists 88 studies for Thrombophilia across more than 10 countries. 13 are recruiting or about to start. 27 of them are mainly about Thrombophilia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-23. Counting its 2 narrower conditions too, such as Purpura, Thrombotic Thrombocytopenic: 196 studies, 39 open.
Get an email when these change. Save the Thrombophilia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
HaEmek Medical Center, Israel (4) · University of Calgary (2) · Hospices Civils de Lyon (2) · Rigshospitalet, Denmark (2) · Assistance Publique - Hôpitaux de Paris (2) · Central Hospital, Nancy, France (2) · Hopital Lariboisière (2) · Emory University (1)
What is being tested here
Drugs under test in Thrombophilia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Nov 2026Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects · Charite University, Berlin, Germany
- Dec 2026Fertility, Hypercoagulability, and Inflammation (FREYA) Registry · Brigham and Women's Hospital
- Jan 2027Observational Dutch Young Symptomatic StrokE studY - nEXT · Radboud University Medical Center
Who these studies take
Of the 10 Thrombophilia studies recruiting now, 6 (60%) set no upper age limit and 4 (40%) stop at 75 or younger. 3 (30%) take children under 18. 2 (20%) are for women only and 0 (0%) for men only; 3 (30%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (20%) | 2 (20%) |
| 18 | 10 (100%) | 8 (80%) |
| 30 | 10 (100%) | 8 (80%) |
| 40 | 10 (100%) | 8 (80%) |
| 50 | 9 (90%) | 8 (80%) |
| 65 | 8 (80%) | 7 (70%) |
| 75 | 7 (70%) | 6 (60%) |
| 85 | 6 (60%) | 5 (50%) |
Across all 88 studies, recruiting or not: 36% stop at 75 or younger and 27% at 65; 24% take children; 39% are for women only and 1% for men only; 28% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 88. Browse all 88 → or search them.
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruitingNCT043986281 country
- Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With ThrombophiliaRecruitingNCT075710961 country
- The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityRecruitingNCT06494878Phase 37 countries
- Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS PatientsRecruitingNCT073721701 country
- Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic SubjectsNot yet recruitingNCT07377097Not applicable
- Hematological Disorders in EHPVO PatientsNot yet recruitingNCT07108023
- Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT067276691 country
- Thrombophilia and Thrombosis in Behçet's DiseaseRecruitingNCT064515751 country
- Prolonged Hypercoagulability Following Major Liver Resection for MalignancyNot yet recruitingNCT06153394Phase 31 country
- Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory FailureRecruitingNCT05540834Phase 21 country
- Thrombophilia Assessment Under DOAC: Effectiveness of Activated CharcoalRecruitingNCT061719841 country
- Observational Dutch Young Symptomatic StrokE studY - nEXTRecruitingNCT058537961 country
- Study of Erythrocyte Parameters and Hypercoagulability in Sickle Cell Disease (SCD-TGA)RecruitingNCT053760461 country
- Effects of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, and Clinical Outcomes in Patients With Pneumonia and SepsisCompletedNCT07892794Phase 21 country
- Fertility, Hypercoagulability, and Inflammation (FREYA) RegistryActive, not recruitingNCT045374161 country
- Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell TraitCompletedNCT043491891 country
- Evaluation of Precision and Accuracy of INR Measurements in a Point of Care DeviceCompletedNCT036824191 country
- Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk FactorCompletedNCT073421271 country
- Arterial Microcirculation, Macrocirculation and ThrombophiliasTerminatedNCT011601591 country
- Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic Disbalansces-focusing Diabetic PregnanciesCompletedNCT073377591 country
- Determination of Reference Values for Diluted Russell's Viper Venom Time (dRVVT) Specific to Pregnant Women (GRAPL)CompletedNCT061336211 country
- Venous Thromboembolism in Myotonic Dystrophy Type 1CompletedNCT03424460Not applicable1 country
- Evaluating Off-label Use of Direct Oral Anticoagulants (DOACs) in Hypercoagulable StatesCompletedNCT045659771 country
- Difference Between Mean Gestational Sac Diameter and Crown-rump Length as a Marker of First-trimester Pregnancy Outcome in Patients With Recurrent Spontaneous AbortionCompletedNCT060815561 country
- Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityCompletedNCT04153760Early Phase 14 countries
- Effect of DT56a (Femarelle) on the Coagulation System in the Treatment of Postmenopausal WomenCompletedNCT008832721 country
- Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With ThrombophiliaCompletedNCT058783271 country
- Effect of Phototherapy With Exercise on Coagulation in ElderlyCompletedNCT04503317Not applicable1 country
- Therapeutic Plasma Exchange for COVID-19-associated HyperviscosityCompletedNCT04441996Phase 41 country
- Extracorporeal Blood Purification as a Treatment Modality for COVID-19CompletedNCT044785391 country
- Thrombophilia Screening After Severe IUGRStatus unknownNCT055510781 country
- Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization TreatmentCompletedNCT052251551 country
- Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)Status unknownNCT03625726Not applicable1 country
- AntiCoagulation Tracking InterVention and EvaluationWithdrawnNCT04059965Not applicable
- Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19CompletedNCT047369011 country
- New Genetic Mutations in Thromboembolic Venous Disease Idiopathic. Study "FIT GENETIQUE".CompletedNCT028410851 country
- Embolism in COVID-19 Positive PatientsStatus unknownNCT049103601 country
- Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis PatientsCompletedNCT050125011 country
- Thrombin Generation in Beta-thalassemia MajorStatus unknownNCT04962984Not applicable
- Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical TrialCompletedNCT02600260Not applicable1 country
- Cardiac Structure, Function, and Clinical Manifestations in MINOCACompletedNCT03572023Not applicable1 country
- Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in VenetoCompletedNCT043938051 country
- COVID-19 Associated Coagulopathy in EgyptCompletedNCT045072301 country
- Blood Markers in Adult Patients With Sudden Sensorineural Hearing Loss (SSNHL)CompletedNCT039194741 country
- Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19Status unknownNCT046684041 country
- Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic EventsStatus unknownNCT045193981 country
- Acute Phase Reactions and Thrombophilia in Pediatric Patients With MigraineStatus unknownNCT01905748Not applicable1 country
- Ovarian Hyperstimulation Syndrome in Patients Triggered by GnRH Agonist for Excessive Follicular ResponseTerminatedNCT02701452Not applicable
- EFFects of Thrombophilia on the Outcomes of Assisted Reproduction TechnologiesCompletedNCT024077301 country
- Detecting Hypercoagulability in Morbidly Obese and Non Obese Parturients Following Cesarean Section DeliveryCompletedNCT027189241 country